Boreal Genomics

The companies will co-develop kits, which Trovagene will distribute globally, to analyze ctDNA from blood or urine using next-generation sequencing platforms.

Over the last two years, the Vancouver, British Columbia-based company has been offering the assay as a service to academic and pharmaceutical researchers.

NEW YORK (GenomeWeb News) – Boreal Genomics said today that it has completed an $18 million Series C financing round, which will be used to expand its commercial operations and launch clinical applications.

Peter Rogan has been awarded US Patent No. 8,532,934, "Rapid and comprehensive identification of prokaryotic organisms by metagenomic analysis."

This article has been updated to correct that cell-free DNA, not plasma, is injected into the cartridge.

Boreal Genomics now has reusable cartridges for its Aurora Nucleic Acid Extraction System. The cartridges are provided with gel casting accessories and can be refilled many times in order to reduce per-sample purification costs.

Boreal Genomics has launched an early access program for its OnTarget Allele Enrichment System, which depletes wild-type alleles to improve detection of known and unknown rare cancer mutations.

Agilent Technologies has launched SureSelect XT Human Methyl-Seq and HaloPlex target enrichment systems.

Fluidigm this week launched two products related to next-generation sequencing: the Access Array Barcode Library for Life Technologies' Ion Torrent PGM sequencer and Access Array Target-Specific Primers for targeted resequencing.

Pages

A fire at a Manchester hospital may have destroyed lab equipment and data, the Guardian reports.

Researchers generate a genetic database from skeletal remains from the 1845 Franklin Expedition to the Arctic, Live Science reports.

Researchers in China have begun another trial using CRISPR/Cas9 approaches in cancer patients, according to the Wall Street Journal.

In Science this week: human DNA found in sediments from archeological sites lacking bones, and more.